Max Robotics — Global Service Robot Directory + US Certification

About

Gianpaolo Balzano is a leading figure in pancreatic surgery, whose work has fundamentally reshaped the debate around minimally invasive approaches for pancreatic cancer. His research centers on comparing the oncological safety and long-term outcomes of minimally invasive distal pancreatectomy (MIDP) against traditional open surgery. Dr. Balzano’s most impactful contribution is his leadership in the landmark DIPLOMA trial, an international randomized non-inferiority study that provided crucial evidence on the safety and efficacy of MIDP for resectable pancreatic ductal adenocarcinoma. The initial 2017 paper, cited over 280 times, set the stage, while the definitive 2023 trial results, with 121 citations, offered rigorous, practice-changing data. His work extends to evaluating outcomes after minimally invasive total pancreatectomy and surveying surgical practices across Europe, highlighting his commitment to standardizing and improving perioperative care. By generating high-level evidence from multicenter collaborations, Dr. Balzano has empowered surgeons to make informed decisions, ultimately advancing the field toward safer, less invasive treatment options for patients facing pancreatic cancer.